Symbols / EW Stock $81.38 +0.05% Edwards Lifesciences Corporation

Healthcare • Medical Devices • United States • NYQ
EW (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Bernard J. Zovighian
Exch · Country NYQ · United States
Market Cap 46.86B
Enterprise Value 43.89B
Income 1.08B
Sales 6.30B
FCF (ttm) 902.14M
Book/sh 17.80
Cash/sh 6.38
Employees 16,000
Insider 10d —
IPO Mar 27, 2000
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 43.99
Forward P/E 24.20
PEG 1.96
P/S 7.43
P/B 4.57
P/C —
EV/EBITDA 23.06
EV/Sales 6.96
Quick Ratio 3.30
Current Ratio 4.42
Debt/Eq 6.81
LT Debt/Eq —
EPS (ttm) 1.85
EPS next Y 3.36
EPS Growth 8.20%
Revenue Growth 16.70%
EPS Gr Q/Q 6.30%
Rev Gr Q/Q —
Earnings (next) 2026-07-23
Earnings (prior) 2026-04-23
ROA 8.27%
ROE 10.46%
ROIC —
Gross Margin 77.87%
Oper. Margin 31.22%
Profit Margin 17.39%
Shs Outstand 575.80M
Shs Float 573.98M
Insider Own 0.19%
Instit Own 89.26%
Short Float 2.08%
Short Ratio 1.92
Short Interest 10.54M
52W High 87.89
vs 52W High -7.41%
52W Low 72.30
vs 52W Low 12.56%
Beta 0.87
Impl. Vol. 32.03%
Rel Volume 0.95
Avg Volume 4.94M
Volume 4.67M
Target (mean) $97.15
Tgt Median $100.00
Tgt Low $84.00
Tgt High $110.00
# Analysts 27
Recom Buy
Prev Close $81.34
Price $81.38
Change 0.05%
About

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$97.15
Mean price target
2. Current target
$81.38
Latest analyst target
3. DCF / Fair value
$28.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$81.38
Low
$84.00
High
$110.00
Mean
$97.15

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-27 main Barclays Overweight → Overweight $110
2026-04-24 main Evercore ISI Group Outperform → Outperform $93
2026-04-24 main Truist Securities Hold → Hold $90
2026-04-24 main Canaccord Genuity Hold → Hold $85
2026-04-24 main BTIG Buy → Buy $100
2026-04-24 main Baird Neutral → Neutral $87
2026-04-13 main Mizuho Outperform → Outperform $95
2026-04-06 main Evercore ISI Group Outperform → Outperform $92
2026-02-11 main Goldman Sachs Buy → Buy $95
2026-02-11 reit Piper Sandler Overweight → Overweight $100
2026-02-11 main Truist Securities Hold → Hold $89
2026-02-11 main Wells Fargo Overweight → Overweight $100
2026-02-11 reit BTIG Buy → Buy $103
2026-01-20 main Stifel Buy → Buy $110
2026-01-20 main Piper Sandler Overweight → Overweight $98
2026-01-12 main UBS Neutral → Neutral $95
2026-01-12 main Barclays Overweight → Overweight $104
2026-01-09 up TD Cowen Hold → Buy $97
2026-01-07 main Stifel Buy → Buy $105
2025-12-18 up JP Morgan Neutral → Overweight $100
News
RSS: Latest EW news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-12 ZOVIGHIAN BERNARD J Chief Executive Officer — 26,640 $0.00 $0
2026-05-12 ZOVIGHIAN BERNARD J Chief Executive Officer — 36,351 $77.92 $2,833,013
2026-05-11 CHOPRA DAVEEN Officer — 13,583 — —
2026-05-11 ZOVIGHIAN BERNARD J Chief Executive Officer — 47,207 — —
2026-05-11 ULLEM SCOTT B Chief Financial Officer — 19,830 — —
2026-05-11 BOBO DONALD E JR Officer — 13,457 — —
2026-05-11 ZOVIGHIAN BERNARD J Chief Executive Officer — 9,711 $0.00 $0
2026-05-11 MARKOWITZ WAYNE Officer — 593 $79.73 $47,280
2026-05-08 LAVIOLETTE PAUL A Director — 3,251 $0.00 $0
2026-05-08 FEINBERG DAVID T Director — 3,251 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
6,067.60
+11.55%
5,439.50
+8.57%
5,010.00
+12.23%
4,464.00
Operating Revenue
6,067.60
+11.55%
5,439.50
+8.57%
5,010.00
+12.23%
4,464.00
Cost Of Revenue
1,334.20
+19.39%
1,117.50
+14.22%
978.40
+35.19%
723.70
Reconciled Cost Of Revenue
1,334.20
+19.39%
1,117.50
+14.22%
978.40
+35.19%
723.70
Gross Profit
4,733.40
+9.52%
4,322.00
+7.20%
4,031.60
+7.79%
3,740.30
Operating Expense
3,097.20
+8.98%
2,841.90
+11.65%
2,545.40
+15.64%
2,201.20
Research And Development
1,079.20
+2.49%
1,053.00
+9.36%
962.90
+14.14%
843.60
Selling General And Administration
2,085.20
+16.54%
1,789.20
+13.06%
1,582.50
+16.57%
1,357.60
General And Administrative Expense
—
—
1,823.40
+16.40%
1,566.50
Salaries And Wages
—
—
-1.20
-9.09%
-1.10
Other Gand A
—
—
1,824.60
+16.39%
1,567.60
Other Operating Expenses
-67.20
-22300.00%
-0.30
—
—
Total Expenses
4,431.40
+11.92%
3,959.40
+12.36%
3,523.80
+20.48%
2,924.90
Operating Income
1,636.20
+10.55%
1,480.10
-0.41%
1,486.20
-3.44%
1,539.10
Total Operating Income As Reported
1,264.20
-8.30%
1,378.70
+5.33%
1,308.90
-12.65%
1,498.40
EBITDA
1,449.90
-15.86%
1,723.10
+12.26%
1,534.90
-8.54%
1,678.30
Normalized EBITDA
1,964.80
+11.45%
1,763.00
+3.53%
1,702.90
-0.72%
1,715.30
Reconciled Depreciation
156.60
+0.90%
155.20
+7.11%
144.90
+3.80%
139.60
EBIT
1,293.30
-17.51%
1,567.90
+12.80%
1,390.00
-9.66%
1,538.70
Total Unusual Items
-514.90
-1190.48%
-39.90
+76.25%
-168.00
-354.05%
-37.00
Total Unusual Items Excluding Goodwill
-514.90
-1190.48%
-39.90
+76.25%
-168.00
-354.05%
-37.00
Special Income Charges
-518.90
-411.74%
-101.40
+42.81%
-177.30
-380.49%
-36.90
Other Special Charges
325.40
+705.45%
40.40
-80.15%
203.50
+1595.83%
12.00
Impairment Of Capital Assets
40.00
0.00
0.00
—
Restructuring And Mergern Acquisition
6.60
-89.18%
61.00
+332.82%
-26.20
-205.22%
24.90
Write Off
146.90
0.00
0.00
—
Net Income
1,073.50
-74.28%
4,174.60
+197.68%
1,402.40
-7.85%
1,521.90
Pretax Income
1,272.90
-17.78%
1,548.10
+12.80%
1,372.40
-9.68%
1,519.50
Net Non Operating Interest Income Expense
148.40
+47.66%
100.50
+102.62%
49.60
+204.29%
16.30
Interest Expense Non Operating
20.40
+3.03%
19.80
+12.50%
17.60
-8.33%
19.20
Net Interest Income
148.40
+47.66%
100.50
+102.62%
49.60
+204.29%
16.30
Interest Expense
20.40
+3.03%
19.80
+12.50%
17.60
-8.33%
19.20
Interest Income Non Operating
168.80
+40.32%
120.30
+79.02%
67.20
+89.30%
35.50
Interest Income
168.80
+40.32%
120.30
+79.02%
67.20
+89.30%
35.50
Other Income Expense
-511.70
-1474.46%
-32.50
+80.11%
-163.40
-355.15%
-35.90
Other Non Operating Income Expenses
3.20
-56.76%
7.40
+60.87%
4.60
+318.18%
1.10
Gain On Sale Of Security
4.00
-93.50%
61.50
+561.29%
9.30
+9400.00%
-0.10
Gain On Sale Of Business
—
—
-17.20
+71.66%
-60.70
Tax Provision
216.90
+42.60%
152.10
-0.20%
152.40
-22.05%
195.50
Tax Rate For Calcs
0.00
+73.43%
0.00
-11.49%
0.00
-13.73%
0.00
Tax Effect Of Unusual Items
-87.74
-2138.13%
-3.92
+78.98%
-18.65
-291.73%
-4.76
Net Income Including Noncontrolling Interests
1,069.40
-74.35%
4,169.70
+197.96%
1,399.40
-8.05%
1,521.90
Net Income From Continuing Operation Net Minority Interest
1,060.10
-24.33%
1,400.90
+14.55%
1,223.00
-7.63%
1,324.00
Net Income From Continuing And Discontinued Operation
1,073.50
-74.28%
4,174.60
+197.68%
1,402.40
-7.85%
1,521.90
Net Income Continuous Operations
1,056.00
-24.36%
1,396.00
+14.43%
1,220.00
-7.85%
1,324.00
Net Income Discontinuous Operations
13.40
-99.52%
2,773.70
+1446.10%
179.40
-9.35%
197.90
Minority Interests
4.10
-16.33%
4.90
+63.33%
3.00
0.00
Normalized Income
1,487.26
+3.51%
1,436.88
+4.70%
1,372.35
+1.19%
1,356.24
Net Income Common Stockholders
1,073.50
-74.28%
4,174.60
+197.68%
1,402.40
-7.85%
1,521.90
Diluted EPS
1.83
-73.74%
6.97
+203.04%
2.30
-5.74%
2.44
Basic EPS
1.84
-73.64%
6.98
+202.16%
2.31
-6.10%
2.46
Basic Average Shares
584.80
-2.16%
597.70
-1.48%
606.70
-1.99%
619.00
Diluted Average Shares
585.80
-2.25%
599.30
-1.66%
609.40
-2.37%
624.20
Diluted NI Availto Com Stockholders
1,073.50
-74.28%
4,174.60
+197.68%
1,402.40
-7.85%
1,521.90
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
13,697.20
+4.92%
13,055.30
+39.43%
9,363.20
+12.91%
8,292.50
Current Assets
6,738.90
+7.22%
6,285.40
+55.74%
4,035.70
+30.36%
3,095.80
Cash Cash Equivalents And Short Term Investments
4,226.30
+6.30%
3,975.90
+143.50%
1,632.80
+34.35%
1,215.30
Cash And Cash Equivalents
2,938.00
-3.52%
3,045.20
+168.94%
1,132.30
+47.24%
769.00
Other Short Term Investments
1,288.30
+38.42%
930.70
+85.95%
500.50
+12.14%
446.30
Receivables
912.10
+25.39%
727.40
-12.16%
828.10
+18.45%
699.10
Accounts Receivable
659.60
+8.29%
609.10
-21.05%
771.50
+19.98%
643.00
Gross Accounts Receivable
674.60
+8.68%
620.70
-20.39%
779.70
+19.79%
650.90
Allowance For Doubtful Accounts Receivable
-15.00
-29.31%
-11.60
-41.46%
-8.20
-3.80%
-7.90
Other Receivables
252.50
+113.44%
118.30
+109.01%
56.60
+0.89%
56.10
Inventory
1,126.20
+3.63%
1,086.70
+20.28%
903.50
+3.20%
875.50
Raw Materials
196.60
-18.46%
241.10
+22.82%
196.30
+25.51%
156.40
Work In Process
252.90
+7.07%
236.20
+20.63%
195.80
+10.37%
177.40
Finished Goods
676.70
+11.04%
609.40
+19.16%
511.40
-5.59%
541.70
Prepaid Assets
135.00
+11.57%
121.00
-6.06%
128.80
+17.09%
110.00
Assets Held For Sale Current
0.00
-100.00%
26.80
-91.56%
317.60
—
Other Current Assets
339.30
-2.39%
347.60
+54.56%
224.90
+14.80%
195.90
Total Non Current Assets
6,958.30
+2.78%
6,769.90
+27.07%
5,327.50
+2.52%
5,196.70
Net PPE
1,914.60
+7.31%
1,784.20
+6.49%
1,675.40
-2.88%
1,725.10
Gross PPE
2,764.40
+7.20%
2,578.70
+8.62%
2,374.00
-4.10%
2,475.50
Accumulated Depreciation
-849.80
-6.96%
-794.50
-13.73%
-698.60
+6.90%
-750.40
Properties
0.00
0.00
0.00
0.00
Land And Improvements
152.40
+23.00%
123.90
+10.23%
112.40
-3.35%
116.30
Buildings And Improvements
1,393.30
+3.99%
1,339.80
+12.68%
1,189.00
-0.02%
1,189.20
Machinery Furniture Equipment
814.80
+5.43%
772.80
+11.08%
695.70
-11.39%
785.10
Construction In Progress
301.20
+23.44%
244.00
-16.58%
292.50
+14.62%
255.20
Other Properties
102.70
+4.58%
98.20
+16.35%
84.40
-34.93%
129.70
Goodwill And Other Intangible Assets
2,896.80
-1.91%
2,953.30
+91.21%
1,544.50
+6.55%
1,449.50
Goodwill
1,768.60
-0.46%
1,776.70
+55.16%
1,145.10
-1.65%
1,164.30
Other Intangible Assets
1,128.20
-4.11%
1,176.60
+194.59%
399.40
+40.04%
285.20
Investments And Advances
278.60
-9.52%
307.90
-47.27%
583.90
-52.87%
1,239.00
Long Term Equity Investment
34.70
—
—
—
Non Current Accounts Receivable
314.80
+7.11%
293.90
—
—
Non Current Deferred Assets
1,138.10
+14.72%
992.10
+32.39%
749.40
+54.83%
484.00
Non Current Deferred Taxes Assets
1,138.10
+14.72%
992.10
+32.39%
749.40
+54.83%
484.00
Non Current Prepaid Assets
93.30
-8.17%
101.60
—
—
Other Non Current Assets
142.60
-17.52%
172.90
-77.67%
774.30
+158.88%
299.10
Total Liabilities Net Minority Interest
3,359.60
+12.27%
2,992.40
+13.19%
2,643.80
+6.36%
2,485.80
Current Liabilities
1,813.70
+20.50%
1,505.20
+25.92%
1,195.40
+16.92%
1,022.40
Payables And Accrued Expenses
1,095.80
+11.20%
985.40
+53.42%
642.30
-7.17%
691.90
Payables
504.90
-11.75%
572.10
+95.19%
293.10
-1.68%
298.10
Accounts Payable
227.50
+15.25%
197.40
+5.79%
186.60
-7.58%
201.90
Current Accrued Expenses
590.90
+42.97%
413.30
+18.36%
349.20
-11.33%
393.80
Pensionand Other Post Retirement Benefit Plans Current
467.50
+30.37%
358.60
+13.34%
316.40
+17.75%
268.70
Total Tax Payable
277.40
-25.97%
374.70
+251.83%
106.50
+10.71%
96.20
Current Debt And Capital Lease Obligation
24.50
+4.70%
23.40
+2.18%
22.90
-10.20%
25.50
Current Capital Lease Obligation
24.50
+4.70%
23.40
+2.18%
22.90
-10.20%
25.50
Current Deferred Liabilities
27.20
-49.35%
53.70
0.00
—
Current Deferred Revenue
27.20
-49.35%
53.70
0.00
—
Other Current Liabilities
148.70
+1343.69%
10.30
-92.88%
144.70
+599.03%
20.70
Total Non Current Liabilities Net Minority Interest
1,545.90
+3.95%
1,487.20
+2.68%
1,448.40
-1.03%
1,463.40
Liabilities Heldfor Sale Non Current
—
0.00
-100.00%
25.10
—
Long Term Debt And Capital Lease Obligation
680.90
+0.64%
676.60
+2.17%
662.20
-0.54%
665.80
Long Term Debt
598.30
+0.10%
597.70
+0.12%
597.00
+0.12%
596.30
Long Term Capital Lease Obligation
82.60
+4.69%
78.90
+21.01%
65.20
-6.19%
69.50
Tradeand Other Payables Non Current
—
1.30
-98.39%
80.60
-43.79%
143.40
Other Non Current Liabilities
865.00
+14.13%
757.90
+29.27%
586.30
+14.69%
511.20
Stockholders Equity
10,337.60
+3.39%
9,998.40
+50.35%
6,650.00
+14.52%
5,806.70
Capital Stock
658.70
+0.60%
654.80
+0.66%
650.50
+0.65%
646.30
Common Stock
658.70
+0.60%
654.80
+0.66%
650.50
+0.65%
646.30
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
658.70
+0.60%
654.80
+0.66%
650.50
+0.65%
646.30
Ordinary Shares Number
580.70
-1.34%
588.60
-2.08%
601.10
-1.18%
608.30
Treasury Shares Number
78.00
+17.82%
66.20
+34.01%
49.40
+30.00%
38.00
Additional Paid In Capital
2,768.40
+5.93%
2,613.40
+14.91%
2,274.40
+15.49%
1,969.30
Retained Earnings
14,240.50
+8.15%
13,167.00
+46.42%
8,992.40
+18.48%
7,590.00
Gains Losses Not Affecting Retained Earnings
-238.30
+2.54%
-244.50
-0.70%
-242.80
+4.75%
-254.90
Treasury Stock
7,091.70
+14.52%
6,192.30
+23.24%
5,024.50
+21.25%
4,144.00
Minority Interest
0.00
-100.00%
64.50
-7.06%
69.40
0.00
Other Equity Adjustments
-238.30
+2.54%
-244.50
-0.70%
-242.80
+4.75%
-254.90
Total Equity Gross Minority Interest
10,337.60
+2.73%
10,062.90
+49.76%
6,719.40
+15.72%
5,806.70
Total Capitalization
10,935.90
+3.21%
10,596.10
+46.21%
7,247.00
+13.18%
6,403.00
Working Capital
4,925.20
+3.03%
4,780.20
+68.30%
2,840.30
+36.99%
2,073.40
Invested Capital
10,935.90
+3.21%
10,596.10
+46.21%
7,247.00
+13.18%
6,403.00
Total Debt
705.40
+0.77%
700.00
+2.17%
685.10
-0.90%
691.30
Capital Lease Obligations
107.10
+4.69%
102.30
+16.12%
88.10
-7.26%
95.00
Net Tangible Assets
7,440.80
+5.62%
7,045.10
+37.99%
5,105.50
+17.17%
4,357.20
Tangible Book Value
7,440.80
+5.62%
7,045.10
+37.99%
5,105.50
+17.17%
4,357.20
Available For Sale Securities
243.90
—
—
—
Current Provisions
50.00
-32.25%
73.80
+6.80%
69.10
+342.95%
15.60
Financial Assets
5.80
-83.29%
34.70
—
—
Investmentin Financial Assets
243.90
—
—
—
Non Current Accrued Expenses
0.00
-100.00%
52.70
-44.06%
94.20
-34.13%
143.00
Non Current Note Receivables
173.70
+34.34%
129.30
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,595.20
+194.15%
542.30
-39.46%
895.80
-26.47%
1,218.20
Cash Flow From Continuing Operating Activities
1,595.20
+194.15%
542.30
-39.46%
895.80
-26.47%
1,218.20
Net Income From Continuing Operations
1,069.40
-74.35%
4,169.70
+197.96%
1,399.40
-8.05%
1,521.90
Depreciation Amortization Depletion
156.60
+0.90%
155.20
+7.11%
144.90
+3.80%
139.60
Depreciation
—
—
138.90
+3.73%
133.90
Amortization Cash Flow
—
—
6.10
+7.02%
5.70
Depreciation And Amortization
156.60
+0.90%
155.20
+7.11%
144.90
+3.80%
139.60
Amortization Of Intangibles
—
—
6.10
+7.02%
5.70
Other Non Cash Items
-12.80
+99.62%
-3,362.20
-32120.95%
10.50
+1412.50%
-0.80
Stock Based Compensation
158.10
-2.59%
162.30
+16.43%
139.40
+9.94%
126.80
Asset Impairment Charge
186.90
0.00
0.00
-100.00%
55.10
Deferred Tax
-117.60
+63.64%
-323.40
-18.85%
-272.10
-6.92%
-254.50
Deferred Income Tax
-117.60
+63.64%
-323.40
-18.85%
-272.10
-6.92%
-254.50
Operating Gains Losses
—
-5.20
-5300.00%
0.10
-99.81%
51.50
Gain Loss On Investment Securities
—
-5.20
-5300.00%
0.10
-99.81%
51.50
Change In Working Capital
154.60
+159.62%
-259.30
+50.73%
-526.30
-24.89%
-421.40
Change In Receivables
-23.00
-118.98%
121.20
+185.84%
-141.20
-67.90%
-84.10
Change In Inventory
50.70
+119.80%
-256.10
+11.38%
-289.00
-35.43%
-213.40
Change In Prepaid Assets
-15.40
-149.68%
31.00
+116.17%
-191.70
-191800.00%
0.10
Change In Payables And Accrued Expense
318.60
+504.55%
52.70
-53.36%
113.00
+270.18%
-66.40
Change In Accrued Expense
-76.50
-107.88%
-36.80
-11.52%
-33.00
+26.67%
-45.00
Change In Payable
395.10
+341.45%
89.50
-38.70%
146.00
+782.24%
-21.40
Change In Account Payable
395.10
+341.45%
89.50
-38.70%
146.00
+782.24%
-21.40
Change In Other Working Capital
-176.30
+15.28%
-208.10
-1095.98%
-17.40
+69.79%
-57.60
Investing Cash Flow
-712.90
-130.82%
2,312.90
+1230.78%
173.80
-31.11%
252.30
Cash Flow From Continuing Investing Activities
-712.90
-130.82%
2,312.90
+1230.78%
173.80
-31.11%
252.30
Capital Expenditure
-260.20
+7.86%
-282.40
-6.05%
-266.30
-0.57%
-264.80
Capital Expenditure Reported
-260.20
-3.09%
-252.40
+0.24%
-253.00
-3.43%
-244.60
Net Investment Purchase And Sale
-282.10
-109.90%
-134.40
-122.02%
610.30
+5.19%
580.20
Purchase Of Investment
-3,160.20
-218.57%
-992.00
-840.28%
-105.50
+86.46%
-778.90
Sale Of Investment
2,878.10
+235.60%
857.60
+19.81%
715.80
-47.33%
1,359.10
Net Business Purchase And Sale
-101.10
-103.60%
2,805.30
+2627.30%
-111.00
0.00
Purchase Of Business
-101.10
+90.99%
-1,122.10
-910.90%
-111.00
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-30.00
-125.56%
-13.30
+34.16%
-20.20
Purchase Of Intangibles
0.00
+100.00%
-30.00
-125.56%
-13.30
+34.16%
-20.20
Net Other Investing Changes
-69.50
+8.07%
-75.60
-27.70%
-59.20
+6.18%
-63.10
Financing Cash Flow
-956.80
+2.67%
-983.00
-38.26%
-711.00
+55.13%
-1,584.50
Cash Flow From Continuing Financing Activities
-956.80
+2.67%
-983.00
-38.26%
-711.00
+55.13%
-1,584.50
Net Issuance Payments Of Debt
—
—
-0.30
-50.00%
-0.20
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
—
—
-0.30
-50.00%
-0.20
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
—
—
-0.30
-50.00%
-0.20
Net Long Term Debt Issuance
—
—
-0.30
-50.00%
-0.20
Net Common Stock Issuance
-893.40
+22.94%
-1,159.40
-31.81%
-879.60
+49.07%
-1,727.10
Common Stock Payments
-893.40
+22.94%
-1,159.40
-31.81%
-879.60
+49.07%
-1,727.10
Repurchase Of Capital Stock
-893.40
+22.94%
-1,159.40
-31.81%
-879.60
+49.07%
-1,727.10
Proceeds From Stock Option Exercised
174.10
-3.01%
179.50
+5.65%
169.90
+16.05%
146.40
Net Other Financing Charges
-237.50
-7561.29%
-3.10
-138.46%
-1.30
+65.79%
-3.80
Changes In Cash
-74.50
-103.98%
1,872.20
+422.09%
358.60
+414.56%
-114.00
Effect Of Exchange Rate Changes
-44.80
-216.06%
38.60
+129.76%
16.80
-12.50%
19.20
Beginning Cash Position
3,058.80
+166.45%
1,148.00
+48.59%
772.60
-10.93%
867.40
End Cash Position
2,939.50
-3.90%
3,058.80
+166.45%
1,148.00
+48.59%
772.60
Free Cash Flow
1,335.00
+413.66%
259.90
-58.71%
629.50
-33.97%
953.40
Interest Paid Supplemental Data
—
19.60
-1.51%
19.90
+3.11%
19.30
Income Tax Paid Supplemental Data
—
1,196.10
+154.44%
470.10
-6.74%
504.10
Sale Of Business
—
3,927.40
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category